Clinical Trials Logo

Clinical Trial Summary

This study evaluates patients willingness to participate in a trial comparing standard genetic counseling versus personalized genetic counseling. Collecting information from patients may help researchers learn why patients may or may not take part in the future study that compares standard genetic counseling to personalized genetic counseling.

Clinical Trial Description

PRIMARY OBJECTIVE: I. To evaluate patients' willingness to participate in a future randomized trial comparing standard genetic counseling versus personalized genetic counseling based on Li-Fraumeni syndrome patient reported outcome (LFSPRO) ShinyApp data. OUTLINE: Patients complete a questionnaire over 15-20 minutes. Patients positive for a TP53 mutation complete an additional questionnaire over 15-20 minutes within 1 month after test results. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05126810
Study type Observational
Source M.D. Anderson Cancer Center
Contact Banu Arun
Phone 713-792-2360
Email [email protected]
Status Not yet recruiting
Start date March 1, 2022
Completion date August 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04367246 - Li-Fraumeni Syndrome/TP53 Biobank
Recruiting NCT04541654 - Li-Fraumeni & TP53 (LiFT UP)
Completed NCT01737255 - Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
Recruiting NCT02950987 - Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes N/A
Enrolling by invitation NCT03176836 - Li-Fraumeni Syndrome Imaging Study N/A
Recruiting NCT01143454 - Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Completed NCT02289326 - Biomarker Monitoring in TP53 Mutation Carriers
Recruiting NCT04982744 - Registry of Li Fraumeni and Li Fraumeni Like Syndromes
Completed NCT01981525 - A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome Phase 1
Completed NCT00406445 - Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
Recruiting NCT01443468 - Clinical and Genetic Studies of Li-Fraumeni Syndrome
Recruiting NCT04966923 - Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53
Recruiting NCT03050268 - Familial Investigations of Childhood Cancer Predisposition